Literature DB >> 27002098

Procalcitonin level for prediction of postoperative infection in cardiac surgery.

Pranav Sharma1, Kartik Patel2, Kinnaresh Baria2, Ketav Lakhia2, Amber Malhotra2, Komal Shah3, Sanjay Patel3.   

Abstract

BACKGROUND: Diagnosing infection after cardiac surgery remains difficult due to the systemic inflammatory response induced by cardiopulmonary bypass. We compared procalcitonin levels with white blood cell counts as predictors of infection after cardiac surgery.
METHODS: We prospectively enrolled 100 consecutive adult cardiac patients. Postoperative white blood cell counts, serum procalcitonin levels, and blood cultures were examined. RESULT: The sensitivity and specificity of white blood cell count and procalcitonin > 2 ng mL(-1) were 60% and 100%, 58.8% and 42.5%, respectively. Procalcitonin > 7 ng mL(-1) had 95% sensitivity and 80% specificity. Receiver-operating characteristic analysis showed a greater area under the curve for procalcitonin level (p < 0.0001) compared to white blood cell count (p = 0.31). Patients with positive blood cultures had significantly higher procalcitonin levels (51.97 ± 39.62 vs. 6.67 ± 10.73 ng mL(-1)), Acute Physiology and Chronic Health Evaluation-II scores (16.95 ± 3.24 vs. 13.60 ± 2.98), and intensive care unit stay (6.35 ± 3.42 vs. 4.6 ± 2.2 days). Non-survivors had significantly higher Acute Physiology and Chronic Health Evaluation-II scores (19.09 ± 1.30 vs. 13.67 ± 2.97) and procalcitonin levels (43.83 ± 52.15 vs. 12.26 ± 19.89 ng mL(-1)) but on logistic regression analysis, only Acute Physiology and Chronic Health Evaluation-II score was an independent risk factor for mortality.
CONCLUSION: The diagnostic accuracy of procalcitonin for bacterial infection is fairly high. Acute Physiology and Chronic Health Evaluation-II score is a better predictor of mortality and morbidity than absolute procalcitonin level. Procalcitonin > 7 ng mL(-1) can prognosticate and identify the high-risk group.
© The Author(s) 2016.

Entities:  

Keywords:  Biomarkers; Cardiac surgical procedures; Cardiopulmonary bypass; Leukocyte count; Procalcitonin; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 27002098     DOI: 10.1177/0218492316640953

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  4 in total

Review 1.  Procalcitonin: Where Are We Now?

Authors:  Bachar Hamade; David T Huang
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

2.  Early Kinetics of Procalcitonin in Predicting Surgical Outcomes in Type A Aortic Dissection Patients.

Authors:  Hua Liu; Zhe Luo; Lan Liu; Xiao-Mei Yang; Ya-Min Zhuang; Ying Zhang; Guo-Wei Tu; Guo-Guang Ma; Guang-Wei Hao; Jian-Feng Luo; Ji-Li Zheng; Chun-Sheng Wang
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

3.  Clinico-bacterial and prognostic factors in patients with suspected blood stream infection and elevated serum procalcitonin levels.

Authors:  Yoko Osamura; Hideki Nishiyama; Takuya Hattori; Masaharu Gunji; Norihiro Yuasa
Journal:  Nagoya J Med Sci       Date:  2022-05       Impact factor: 0.794

4.  Role of repeat procalcitonin estimation at 48 hours for outcome in pregnancy associated sepsis: a prospective observational study.

Authors:  Rachna Agarwal; Kavita Sharma; Mohit Mehndiratta; Medha Mohta; Himsweta Srivastava; Almeida Edelbert Anthonio
Journal:  Obstet Gynecol Sci       Date:  2020-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.